In a major regional breakthrough, the Cardiology Centre at Al Qassimi Hospital, part of the Emirates Health Services (EHS), has successfully performed three advanced procedures, known as Pulmonary Artery Denervation (PADN), to treat pulmonary hypertension using catheter ablation. This cutting-edge intervention marks a transformative shift in addressing the chronic condition, which previously relied on intensive drug therapies with limited outcomes.

The new technique, utilized in approximately 1,000 cases worldwide, offers a more effective, economical, and sustainable treatment alternative for patients battling chronic symptoms that severely impact their quality of life. The procedures were conducted by a local medical team from Al Qassimi Hospital’s Cardiology Center, supported by experts from China. All patients were discharged the following day in stable condition, with no reported complications.

Also Read: Three Heart Conditions Now Treatable with New Catheterization Simulator at Al Qassimi Hospital

Dr. Arif Al Nooryani, Director of Al Qassimi Hospital in Sharjah, stated: “The adoption of catheter ablation for pulmonary hypertension represents a practical leap toward enhancing the lives of patients with complex chronic conditions, who previously had limited treatment options. Introducing such advanced procedures underscores our commitment to accelerating the integration of innovative therapies and empowering local medical teams to deliver world-class precision care.” He emphasized that these successes reinforce patient trust and bolster the UAE’s leadership in building a healthcare model focused on tangible outcomes, aligning with the “We the UAE 2031” vision and the UAE Centennial Plan 2071.

This milestone adds to Al Qassimi Hospital’s legacy as a leading cardiac care hub under EHS. By adopting state-of-the-art technologies and sourcing skilled national professionals, the hospital continues to strengthen the UAE’s competitiveness in advanced healthcare regionally and globally.